- Work address:
- Cancer Research UK Cambridge Institute University of Cambridge Li Ka Shing Centre Robinson Way Cambridge CB2 0RE
-
Molecular Determinants of Sensitivity to Polatuzumab Vedotin in Diffuse Large B Cell Lymphoma.
E-pub date: 25 Apr 2024Journal name: Cancer Discov
CRISPR-Cas9 genetic screen leads to the discovery of L-Moses, a KAT2B inhibitor that attenuates Tunicamycin-mediated neuronal cell death.
E-pub date: 9 Mar 2023Journal name: Sci Rep
Multi-omics analyses demonstrate a critical role for EHMT1 methyltransferase in transcriptional repression during oogenesis.
E-pub date: 1 Jan 2023Journal name: Genome Res
- Research Integrity Conflict of Interest Disclosure:
- Last revised:
- –
- No items to report